APPROVED PRODUCTS

Commercial product categories are diverse in the Navinta product portfolio. They include an anticholinergic agent, benztropine mesylate used in the treatment of Parkinson’s disease to ribavirin, a viral RNA polymerase inhibitor, to treat children with respiratory syncytial virus.